Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma

NCT00834665 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: hTERT vaccine, GM-CSF, PCV, T cell infusion
BIOLOGICAL: GM-CSF, PCV, T cell infusion

Sponsor

University of Pennsylvania

Collaborators

[object Object]